Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, ...
Q4 2024 revenue increased 24.6% over Q3 2024; Full-year 2024 revenue grew 97.8% year-over-yearStrong growth in key commercial metrics, including ...
Q4 2024 Earnings Call Transcript March 18, 2025 Operator: Greetings and welcome to the Acurx Pharmaceuticals Fourth Quarter and Full Year 2024 Financial Results and Business Update. At this time, all ...
Operator: Good afternoon, and welcome to the Evoke Pharma, Inc. Fourth Quarter and Full Year 2024 Earnings Conference Call. Currently, all callers have been placed in a listen-only mode.
Secluded from the rest of Guatemala on the east coast, the port town of Livingston has a laid-back, Caribbean-like Garifuna ...
Recent FDA feedback received on SER-155 allogeneic hematopoietic stem cell transplant (allo-HSCT) next study provides support ...
"He eventually muttered, 'You're right, everyone's always been right. I can't believe I got to this point' and kept bawling ...
Q4 2024 Earnings Call Transcript March 13, 2025 Seres Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.1, ...
Bring out the coffin, let the mourners come. Let the traffic policemen wear black cotton gloves. I thought that love would ...
Purple Innovation, Inc. ("Purple" or the "Company"), a comfort innovation company known for creating the "World's First No Pressuretm Mattress," today announced that its Board of Directors (the "Board ...